Disease burden of post-infectious irritable bowel syndrome in The Netherlands
- PMID: 20223049
- DOI: 10.1017/S0950268810000531
Disease burden of post-infectious irritable bowel syndrome in The Netherlands
Abstract
Post-infectious irritable bowel syndrome (PI-IBS) has been established as a sequel of infectious intestinal disease (IID). The aim of this study was to estimate the burden of PI-IBS caused by the pathogens Campylobacter, Salmonella and Shigella, and to compare this with other outcomes associated with these pathogens. The attributable risk of PI-IBS due to bacterial pathogens was calculated and linked to national data on gastroenteritis incidence and measures for severity and duration of illness in order to estimate the burden of PI-IBS. One year post-infection, IBS developed in 9% of patients with bacterial IID. The burden of PI-IBS adds over 2300 disability adjusted life years to the total annual disease burden for the selected pathogens. PI-IBS is a frequent sequel of IID, resulting in a considerable disease burden compared to other outcomes. If this relationship is not considered, this will result in an underestimation of the disease burden of IID.
Similar articles
-
Post-infectious irritable bowel syndrome in patients with Shigella infection.J Gastroenterol Hepatol. 2005 Mar;20(3):381-6. doi: 10.1111/j.1440-1746.2005.03574.x. J Gastroenterol Hepatol. 2005. PMID: 15740480
-
The incidence and risk factors of post-infectious irritable bowel syndrome: a meta-analysis.Hepatogastroenterology. 2012 Jan-Feb;59(113):67-72. doi: 10.5754/hge10796. Hepatogastroenterology. 2012. PMID: 22024145
-
[Post-infectious irritable bowel syndrome].Tunis Med. 2012 Mar;90(3):205-13. Tunis Med. 2012. PMID: 22481191 Review. French.
-
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.Gastroenterology. 2010 Apr;138(4):1502-13. doi: 10.1053/j.gastro.2009.12.049. Epub 2010 Jan 4. Gastroenterology. 2010. PMID: 20044998
-
Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?Scand J Gastroenterol. 2019 May;54(5):546-562. doi: 10.1080/00365521.2019.1607897. Epub 2019 May 21. Scand J Gastroenterol. 2019. PMID: 31112663
Cited by
-
Chicken Immune Response after In Ovo Immunization with Chimeric TLR5 Activating Flagellin of Campylobacter jejuni.PLoS One. 2016 Oct 19;11(10):e0164837. doi: 10.1371/journal.pone.0164837. eCollection 2016. PLoS One. 2016. PMID: 27760175 Free PMC article.
-
The disease burden associated with Campylobacter spp. in Germany, 2014.PLoS One. 2019 May 15;14(5):e0216867. doi: 10.1371/journal.pone.0216867. eCollection 2019. PLoS One. 2019. PMID: 31091282 Free PMC article.
-
Advances in the treatment of travelers' diarrhea.Curr Gastroenterol Rep. 2011 Oct;13(5):402-7. doi: 10.1007/s11894-011-0208-6. Curr Gastroenterol Rep. 2011. PMID: 21773708 Review.
-
Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas.Curr Opin Infect Dis. 2010 Oct;23(5):475-80. doi: 10.1097/QCO.0b013e32833da204. Curr Opin Infect Dis. 2010. PMID: 20689423 Free PMC article. Review.
-
A systematic review of the methodological considerations in Campylobacter burden of disease studies.PLoS Negl Trop Dis. 2025 Apr 22;19(4):e0012681. doi: 10.1371/journal.pntd.0012681. eCollection 2025 Apr. PLoS Negl Trop Dis. 2025. PMID: 40261866 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous